EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseOpen Access · CC BY-NC-ND 4.0

Vaccination for the prevention of equine herpesvirus-1 disease in domesticated horses: A systematic review and meta-analysis

Klaus Osterrieder iD, David C Dorman iD, Brandy A Burgess iD, Lutz S Goehring, Peggy Gross iD, Claire Neinast, Nicola Pusterla, Gisela Soboll Hussey, David P Lunn iD

Journal of Veterinary Internal Medicine · 01.05.2024 · 38 (3) · 1858-1871

DOI: 10.1111/jvim.16895 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Journal of Veterinary Internal Medicine, online erschienen am 01.05.2024. Verfasst von Klaus Osterrieder und 8 weiteren Autor:innen. Beteiligte Einrichtung: Institut für Virologie, Freie Universität Berlin, Berlin, Germany. Hauptthemen laut MEDLINE: Herpesvirus 1, Equid, Horse Diseases, Herpesviridae Infections. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Equine herpes virus type 1 (EHV-1) infection in horses is associated with respiratory and neurologic disease, abortion, and neonatal death. Hypothesis Vaccines decrease the occurrence of clinical disease in EHV-1-infected horses.

Methods

A systematic review was performed searching multiple databases to identify relevant studies. Selection criteria were original peer-reviewed research reports that investigated the in vivo use of vaccines for the prevention of disease caused by EHV-1 in domesticated horses. Main outcomes of interest included pyrexia, abortion, neurologic disease, viremia, and nasal shedding. We evaluated risk of bias, conducted exploratory meta-analyses of incidence data for the main outcomes, and performed a GRADE evaluation of the quality of evidence for each vaccine subtype.

Results

A total of 1018 unique studies were identified, of which 35 met the inclusion criteria. Experimental studies accounted for 31/35 studies, with the remainder being observational studies. Eight vaccine subclasses were identified including commercial (modified-live, inactivated, mixed) and experimental (modified-live, inactivated, deletion mutant, DNA, recombinant). Risk of bias was generally moderate, often because of underreporting of research methods, and sample sizes were small leading to imprecision in the estimate of the effect size. Several studies reported either no benefit or minimal vaccine efficacy for the primary outcomes of interest. Meta-analyses revealed significant heterogeneity was present, and our confidence in the quality of evidence for most outcomes was low to moderate. Conclusions and Clinical Importance Our review indicates that commercial and experimental vaccines minimally reduce the incidence of clinical disease associated with EHV-1 infection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Herpesvirus 1, EquidHorse DiseasesHerpesviridae InfectionsAnimalsHorsesVaccinationHerpesvirus VaccinesViral Vaccines

Stichwörter der Autor:innen

equineequine herpesvirus myeloencephalopathy (EHM)equine herpesvirus‐1 (EHV‐1)vaccination

Substanzen

Herpesvirus VaccinesViral Vaccines

Autor:innen und Institutionen

  • Institut für Virologie, Freie Universität Berlin, Berlin, Germany.
  • College of Veterinary Medicine, North Carolina State University, Raleigh, North Carolina, USA.
  • College of Veterinary Medicine, University of Georgia, Athens, Georgia, USA.
  • College of Agriculture, Food and Environment, University of Kentucky, Maxwell H. Gluck Equine Research Center, Lexington, Kentucky, USA.
  • School of Veterinary Medicine, University of California, Davis, California, USA.
  • College of Veterinary Medicine, Michigan State University, Veterinary Medical Center, East Lansing, Michigan, USA.

ORCID-Profile: Klaus Osterrieder, David C Dorman, Brandy A Burgess, Peggy Gross, David P Lunn

Zitieren

APA

Osterrieder, K., Dorman, D. C., Burgess, B. A., Goehring, L. S., Gross, P., Neinast, C., Pusterla, N., Hussey, G. S., & Lunn, D. P. (2024). Vaccination for the prevention of equine herpesvirus-1 disease in domesticated horses: A systematic review and meta-analysis. Journal of Veterinary Internal Medicine, 38(3), 1858-1871. https://doi.org/10.1111/jvim.16895

Vancouver

Osterrieder K, Dorman DC, Burgess BA, Goehring LS, Gross P, Neinast C, et al. Vaccination for the prevention of equine herpesvirus-1 disease in domesticated horses: A systematic review and meta-analysis. Journal of Veterinary Internal Medicine. 2024;38(3):1858-1871. doi:10.1111/jvim.16895

BibTeX
@article{Osterrieder2024,
  author = {Osterrieder, Klaus and Dorman, David C and Burgess, Brandy A and Goehring, Lutz S and Gross, Peggy and Neinast, Claire and Pusterla, Nicola and Hussey, Gisela Soboll and Lunn, David P},
  title = {Vaccination for the prevention of equine herpesvirus-1 disease in domesticated horses: A systematic review and meta-analysis},
  journal = {Journal of Veterinary Internal Medicine},
  year = {2024},
  volume = {38},
  number = {3},
  pages = {1858--1871},
  doi = {10.1111/jvim.16895}
}
Kostenlos starten →